BrightAccountsProduction v1.0.0 v1.0.0 2023-05-01 The company was not dormant during the period The company was trading for the entire period The principal activity of the company during the year under review was the provision of dental implant solutions and other dental services. 29 November 2024 25 25 SC376673 2024-04-30 SC376673 2023-04-30 SC376673 2022-04-30 SC376673 2023-05-01 2024-04-30 SC376673 2022-05-01 2023-04-30 SC376673 uk-bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 SC376673 uk-curr:PoundSterling 2023-05-01 2024-04-30 SC376673 uk-bus:AbridgedAccounts 2023-05-01 2024-04-30 SC376673 uk-core:ShareCapital 2024-04-30 SC376673 uk-core:ShareCapital 2023-04-30 SC376673 uk-core:RetainedEarningsAccumulatedLosses 2024-04-30 SC376673 uk-core:RetainedEarningsAccumulatedLosses 2023-04-30 SC376673 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2024-04-30 SC376673 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2023-04-30 SC376673 uk-bus:FRS102 2023-05-01 2024-04-30 SC376673 uk-core:LandBuildings 2023-05-01 2024-04-30 SC376673 uk-core:PlantMachinery 2023-05-01 2024-04-30 SC376673 uk-core:FurnitureFittingsToolsEquipment 2023-05-01 2024-04-30 SC376673 uk-bus:Audited 2023-05-01 2024-04-30 SC376673 uk-core:CostValuation 2024-04-30 SC376673 2023-05-01 2024-04-30 SC376673 uk-bus:Director1 2023-05-01 2024-04-30 xbrli:pure iso4217:GBP xbrli:shares
 
 
 
 
 
 
 
 
 
 
 
Belfast Dental Implant Clinic Ltd
 
Abridged Financial Statements
 
for the financial year ended 30 April 2024



Belfast Dental Implant Clinic Ltd
Company Registration Number: SC376673
ABRIDGED BALANCE SHEET
as at 30 April 2024

2024 2023
Notes £ £
 
Fixed Assets
Tangible assets 5 3,171,318 3,050,881
Investments 6 650,001 650,001
───────── ─────────
Fixed Assets 3,821,319 3,700,882
───────── ─────────
 
Current Assets
Stocks 89,617 29,000
Debtors 1,921,342 697,114
Cash and cash equivalents - 427,791
───────── ─────────
2,010,959 1,153,905
───────── ─────────
Creditors: amounts falling due within one year (2,438,618) (2,033,608)
───────── ─────────
Net Current Liabilities (427,659) (879,703)
───────── ─────────
Total Assets less Current Liabilities 3,393,660 2,821,179
 
Creditors:
amounts falling due after more than one year (2,664,355) (2,248,562)
 
Provisions for liabilities (91,863) (71,968)
───────── ─────────
Net Assets 637,442 500,649
═════════ ═════════
 
Capital and Reserves
Called up share capital 100 100
Retained earnings 637,342 500,549
───────── ─────────
Equity attributable to owners of the company 637,442 500,649
═════════ ═════════
 
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).
           
All of the members have consented to the preparation of abridged accounts in accordance with section 444(2A) of the Companies Act 2006.
           
The company has taken advantage of the exemption under section 444 not to file the Abridged Profit and Loss Account and Director's Report.
           
Approved by the Director and authorised for issue on 29 November 2024
           
           
________________________________          
Mr. Stuart Douglas Lutton          
Director          
           



Belfast Dental Implant Clinic Ltd
NOTES TO THE ABRIDGED FINANCIAL STATEMENTS
for the financial year ended 30 April 2024

   
1. General Information
 
Belfast Dental Implant Clinic Ltd is a private company limited by shares incorporated and registered in the Scotland. The registered number of the company is SC376673. The registered office of the company is 3B Ormiston Terrace, Edinburgh, EH12 7SJ, Scotland. The principal place of business is 743-745 Lisburn Road, Belfast, Co. Antrim, BT9 7GW, Northern Ireland.

The financial statements have been represented in Pound Sterling (£) which is also the functional currency of the company.

These financial statements cover the individual entity, Belfast Dental Implant Clinic Ltd for the year ended 30 April 2024.
         
2. Summary of Significant Accounting Policies
 
The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
 
Statement of compliance
The financial statements of the company for the financial year ended 30 April 2024 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
 
Basis of preparation
The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
 
Consolidated accounts
The company is entitled to the exemption in Section 399 of the Companies Act 2006 from the obligation to prepare group accounts.
 
Turnover
Turnover comprises the invoice value of services supplied by the company, exclusive of trade discounts and value added tax. The company recognises revenue associated with the transaction by reference to the stage of completion of the service provided. The outcome of the transaction can be estimated reliably when the amount of revenue can be measured reliably; it is probable that the economic benefits associated with the transaction will flow to the entity; the stage of completion of the transaction at the end of the reporting period can be measured reliably; and the costs incurred for the transaction and the costs to complete the transaction can be measured reliably.
 
Tangible assets and depreciation
Tangible assets are stated at cost or at valuation, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost or valuation of tangible assets, less their estimated residual value, over their expected useful lives as follows:
 
  Land and buildings freehold - 2% Straight line
  Plant and machinery - 20% Straight line or over term of lease
  Fixtures, fittings and equipment - 25% Straight line
 
The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.
 
Leasing and hire purchases
Tangible assets held under leasing and Hire Purchases arrangements which transfer substantially all the risks and rewards of ownership to the company are capitalised and included in the Balance Sheet at their cost or valuation, less depreciation. The corresponding commitments are recorded as liabilities. Payments in respect of these obligations are treated as consisting of capital and interest elements, with interest charged to the Profit and Loss Account.
 
Investments
Investments held as fixed assets are stated at cost less provision for any permanent diminution in value. Income from other investments together with any related tax credit is recognised in the Profit and Loss Account in the financial year in which it is receivable.
 
Stocks
Stocks are valued at the lower of cost and net realisable value. Stocks are determined on a first-in first-out basis. Cost comprises expenditure incurred in the normal course of business in bringing stocks to their present location and condition.  Full provision is made for obsolete and slow moving items. Net realisable value comprises actual or estimated selling price (net of trade discounts) less all further costs to completion or to be incurred in marketing and selling.
 
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
 
Provisions
Provisions are recognised when the company has a present legal or constructive obligation arising as a result of a past event, it is probable that an outflow of economic benefits will be required to settle the obligation and a reliable estimate can be made. Provisions are measured at the present value of the expenditures expected to be required to settle the obligation using a pre-tax rate that reflects current market assessments of the same value of money and the risks specific to the obligation. The increase in the provision due to passage of time is recognised as interest expense.
 
Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
 
Taxation and deferred taxation
Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date.
 
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated at the rates of exchange ruling at the Balance Sheet date. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated at the rates of exchange ruling at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. The resulting exchange differences are dealt with in the Profit and Loss Account.
 
Pensions
The company operates a defined contribution pension scheme for employees. The assets of the scheme are held separately from those of the company. Annual contributions payable to the company's pension scheme are charged to the Profit and Loss Account in the period to which they relate.
 
Research and development
Development expenditure is written off to the Profit and Loss Account in the financial year in which it is incurred.
 
Ordinary share capital
The ordinary share capital of the company is presented as equity.
   
3. INFORMATION RELATING TO THE AUDITOR'S REPORT
 
The Audit Report was unqualified. There were no matters to which the auditor was required to refer by way of emphasis.
 
The financial statements were audited by John MacMahon & Co..
The Auditor's Report was signed by John MacMahon (Senior Statutory Auditor) for and on behalf of John MacMahon & Co. on 29th November 2024.
 
       
4. Employees
 
The average monthly number of employees, including director, during the financial year was as follows:
 
  2024 2023
  Number Number
 
Employees 25 25
  ═════════ ═════════
           
5. Tangible assets
  Land and Plant and Fixtures, Total
  buildings machinery fittings and  
  freehold   equipment  
  £ £ £ £
Cost
At 1 May 2023 2,739,595 575,956 62,302 3,377,853
Additions 101,728 107,964 60,732 270,424
  ───────── ───────── ───────── ─────────
At 30 April 2024 2,841,323 683,920 123,034 3,648,277
  ───────── ───────── ───────── ─────────
Depreciation
At 1 May 2023 - 294,004 32,968 326,972
Charge for the financial year 56,657 73,377 19,953 149,987
  ───────── ───────── ───────── ─────────
At 30 April 2024 56,657 367,381 52,921 476,959
  ───────── ───────── ───────── ─────────
Net book value
At 30 April 2024 2,784,666 316,539 70,113 3,171,318
  ═════════ ═════════ ═════════ ═════════
At 30 April 2023 2,739,595 281,952 29,334 3,050,881
  ═════════ ═════════ ═════════ ═════════
       
6. Investments
  Group and Total
  participating  
  interests/  
  joint ventures  
Investments £ £
Cost
 
At 30 April 2024 650,001 650,001
  ───────── ─────────
Net book value
At 30 April 2024 650,001 650,001
  ═════════ ═════════
At 30 April 2023 650,001 650,001
  ═════════ ═════════
       
7. Details of creditors
 
Security given in respect of creditors
The Bank of Ireland hold a fixed and floating charge over the land and buildings owned by the company in respect of the term loan which totalled £2,419,534 at year end (2023: £2,080,064).
       
8. Financial commitments and guarantees
 
The company operates a defined contribution pension scheme for the benefit of its employees. At the year end, there were outstanding contributions of £3,849 due to the fund (2023: £2,774). These are included in creditors; amounts falling due within one year.
       
9. Director's advances and guarantees
 
During the financial year, the director was in receipt of an advance from the company totalling £139,277. This was an interest free advance and was repayable on demand.
       
10. Related party transactions
 
The company was in receipt of goods totalling £648,880 from a company connected by virtue of common ownership. Of this amount, £353,607 remained outstanding at the year end, which is included in creditors; amounts falling due within one year. The company provided financing to connected companies totalling £1,573,867. These amounts are interest free, repayable on demand and are included in debtors.
       
11. Post balance sheet event
 
On 9th May 2024, New Life Teeth Holdings Limited, a company incorporated in Northern Ireland, acquired all of the share capital of Belfast Dental Implant Clinic Limited by way of a share for share exchange with the existing shareholders. From this date, Belfast Dental Implant Clinic Limited is a wholly owned subsidiary of parent company New Life Teeth Holdings Limited.